|
U.S. Hepatitis Therapy MarketsPublished by: Frost & Sullivan Published: Sep. 1, 1999 Table of Contents
AbstractWith an overwhelming majority of hepatitis patients unresponsive to current treatments, participants in the hepatitis therapy markets are focusing their energies on R&D innovation. This report provides you with an overview of key technological developments in R&D and the benefits of an identified patient base. It includes coverage of major trends, revenue forecasts, product analysis, market share, market drivers and restraints, and more. Profiles of major industry participants are also included. From Frost & Sullivan.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||